BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28784574)

  • 1. Clinical implications of the proliferative ability of the squamous component regarding tumor progression of adenosquamous carcinoma of the pancreas: A preliminary report.
    Hoshimoto S; Hoshi N; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Wakamatsu S; Hoshi S; Hirabayashi K; Ogata Y
    Pancreatology; 2017; 17(5):788-794. PubMed ID: 28784574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosquamous carcinoma in the biliary tract: association of the proliferative ability of the squamous component with its proportion and tumor progression.
    Hoshimoto S; Hoshi S; Hishinuma S; Tomikawa M; Shirakawa H; Ozawa I; Wakamatsu S; Hoshi N; Hirabayashi K; Ogata Y
    Scand J Gastroenterol; 2017 Apr; 52(4):425-430. PubMed ID: 28034323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative outcomes of adenosquamous carcinoma of the pancreas: An analysis of the National Cancer Database.
    Hester CA; Augustine MM; Choti MA; Mansour JC; Minter RM; Polanco PM; Porembka MR; Wang SC; Yopp AC
    J Surg Oncol; 2018 Jul; 118(1):21-30. PubMed ID: 29878370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation and prognosis of adenosquamous carcinoma of the pancreas - Matched-pair analysis with pancreatic ductal adenocarcinoma.
    Kaiser J; Hinz U; Mayer P; Hank T; Niesen W; Hackert T; Gaida MM; Büchler MW; Strobel O
    Eur J Surg Oncol; 2021 Jul; 47(7):1734-1741. PubMed ID: 33622577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological mutational signature in adenosquamous cancer of pancreas: an exploratory study of potentially therapeutic targets.
    Silvestris N; Brunetti O; Pinto R; Petriella D; Argentiero A; Fucci L; Tommasi S; Danza K; De Summa S
    Expert Opin Ther Targets; 2018 May; 22(5):453-461. PubMed ID: 29561217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Squamous/adenosquamous carcinoma of the gallbladder: Analysis of 34 cases and comparison of clinicopathologic features and surgical outcomes with adenocarcinoma.
    Song HW; Chen C; Shen HX; Ma L; Zhao YL; Zhang GJ; Geng ZM; Wang L
    J Surg Oncol; 2015 Nov; 112(6):677-80. PubMed ID: 26458491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma.
    Yan L; Xie F; Yang C; Yu L; Zheng T; Fu J; Yang J
    World J Surg Oncol; 2015 Feb; 13():90. PubMed ID: 25890009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosquamous Carcinoma of the Esophagus: An NCDB-Based Investigation on Comparative Features and Overall Survival in a Rare Tumor.
    Evans M; Liu Y; Chen C; Steuer C; Cassidy R; Landry J; Higgins K; Beitler JJ; Willingham F; Owonikoko TK; Ramalingam SS; Shin DM; Jegadeesh NK; El-Rayes B; Fernandez F; Krasinskas AM; Gillespie T; Saba NF
    Oncology; 2017; 93(5):336-342. PubMed ID: 28848104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A clinicopathological study of adenosquamous carcinoma of the lung].
    Mukaida T; Aoe M; Yamashita M; Date H; Hara K; Andoh A; Shimizu Y
    Kyobu Geka; 1996 Nov; 49(12):975-9; discussion 979-81. PubMed ID: 8936996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinicopathological and immunohistochemical study of gastric cancer with squamous cell carcinoma components: a clinically aggressive tumor.
    Saito S; Hosoya Y; Morishima K; Ui T; Haruta H; Kurashina K; Meguro Y; Zuiki T; Sata N; Fujii H; Matsubara D; Niki T; Lefor AT; Yasuda Y
    J Dig Dis; 2012 Aug; 13(8):407-13. PubMed ID: 22788926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II trial of the super-enhancer inhibitor Minnelide™ in advanced refractory adenosquamous carcinoma of the pancreas.
    Skorupan N; Ahmad MI; Steinberg SM; Trepel JB; Cridebring D; Han H; Von Hoff DD; Alewine C
    Future Oncol; 2022 Jun; 18(20):2475-2481. PubMed ID: 35535581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-L1 expression in pancreatic adenosquamous carcinoma: PD-L1 expression is limited to the squamous component.
    Tanigawa M; Naito Y; Akiba J; Kawahara A; Okabe Y; Ishida Y; Ishikawa H; Hisaka T; Fujita F; Yasunaga M; Shigaki T; Sudo T; Mihara Y; Nakayama M; Kondo R; Kusano H; Shimamatsu K; Okuda K; Akagi Y; Yano H
    Pathol Res Pract; 2018 Dec; 214(12):2069-2074. PubMed ID: 30477643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of histology on prognosis of patients with early-stage cervical cancer treated with radical surgery.
    Rudtanasudjatum K; Charoenkwan K; Khunamornpong S; Siriaunkgul S
    Int J Gynaecol Obstet; 2011 Nov; 115(2):183-7. PubMed ID: 21885048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
    Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
    Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking the Clonal Evolution of Adenosquamous Carcinoma, a Rare Variant of Intraductal Papillary Mucinous Neoplasm of the Pancreas.
    Matsuzaka S; Karasaki H; Ono Y; Ogata M; Oikawa K; Tamakawa S; Chiba S; Muraki M; Yokochi T; Funakoshi H; Kono T; Nagashima K; Mizukami Y
    Pancreas; 2016 Jul; 45(6):915-8. PubMed ID: 27295533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical behaviors and responses to radiation between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas of the cervix.
    Hong JH; Tsai CS; Wang CC; Lai CH; Chen WC; Lee SP; Chang TC; Tseng CJ
    Chang Gung Med J; 2000 Jul; 23(7):396-404. PubMed ID: 10974754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
    Yokoi E; Mabuchi S; Takahashi R; Matsumoto Y; Kuroda H; Kozasa K; Kimura T
    J Gynecol Oncol; 2017 Mar; 28(2):e19. PubMed ID: 28028992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosquamous carcinoma of the lung: surgical management, pathologic characteristics, and prognostic implications.
    Mordant P; Grand B; Cazes A; Foucault C; Dujon A; Le Pimpec Barthes F; Riquet M
    Ann Thorac Surg; 2013 Apr; 95(4):1189-95. PubMed ID: 23473060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosquamous carcinoma of the gallbladder: a clinicopathological, immunohistochemical and flow-cytometric study of twenty cases.
    Nishihara K; Nagai E; Izumi Y; Yamaguchi K; Tsuneyoshi M
    Jpn J Cancer Res; 1994 Apr; 85(4):389-99. PubMed ID: 7911122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.